Estimation of Risk Factors for Cardiogenic Shock in Takotsubo Cardiomyopathy: A Retrospective Study

Gaurang Nandkishor Vaidya, Bhaskara Madhira

Abstract


Introduction: Presentation of Takotsubo cardiomyopathy(TCM) widely varies amongst the patients, ranging from asymptomatic patients to cardiogenic shock or even cardiac arrest. The underlying risk factors inherent to the patient that predispose to a catastrophic presentation have not been delineated well in the past.

Objective: To distinguish risk factors and presenting characteristics of patients diagnosed with cardiogenic shock from TCM.

Methods: Total 51 angiography-confirmed TCM patients admitted in Upstate Hospital from 2010 – 2014 were compared retrospectively, 13 presenting with cardiogenic shock.

Results: While TCM was predominantly common in elderly females, four of the total six male TCM patients presented with shock (Odds ratio= 8.0, p=0.027). TSH was higher in cardiogenic shock group. Patients with shock had significantly higher incidence of ST elevations on EKG and higher peak troponins. Moreover, ST elevations were predominantly in the inferior, anteroseptal and lateral leads in the shock group as compared to only the septal leads in the control group. Echocardiography revealed lower LV ejection fraction, LV outflow tract obstruction and concomitant significant mitral regurgitation in shock patients. No correlation was found with age, BMI, coronary disease risk factors (diabetes, hypertension, smoking), coincident infection, electrolyte imbalance, QTc interval length.

Conclusion: Risk factors and pathophysiology for cardiogenic shock in TCM were identified. TCM in males is rare, but male gender is a risk factor for shock.


Keywords


Takotsubo, cardiogenic shock, echocardiography, heart failure, critical care

Full Text:

439

References


Tsuchihashi K, Ueshima K, Uchida T, et al. Transient left ventricular apical ballooning without coronary artery stenosis: A novel heart syndrome mimicking acute myocardial infarction. Angina pectoris-myocardial infarction investigations in japan. J Am Coll Cardiol. 2001;38(1):11-18. DOI: 10.1016/S0735-1097(01)01316-X

Lyon AR, Bossone E, Schneider B, et al. Current state of knowledge on takotsubo syndrome: A position statement from the taskforce on takotsubo syndrome of the heart failure association of the ack an society of cardiology. Eur J Heart Fail. 2016;18(1):8-27. DOI: 10.1002/ejhf.424

Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E. Apical ballooning syndrome or takotsubo cardiomyopathy: A systematic review. Eur Heart J. 2006;27(13):1523-1529. DOI: 10.1093/eurheartj/ehl032

Merchant EE, Johnson SW, Nguyen P, Kang C, Mallon WK. Takotsubo cardiomyopathy: A case series and review of the literature. West J Emerg Med. 2008;9(2):104-111.

Kawaji T, Shiomi H, Morimoto T, et al. Clinical impact of left ventricular outflow tract obstruction in takotsubo cardiomyopathy. Circ J. 2015;79(4):839-846. DOI: 10.1253/circj.CJ-14-1148

Brinjikji W, El-Sayed AM, Salka S. In-hospital mortality among patients with takotsubo cardiomyopathy: A study of the national inpatient sample 2008 to 2009. Am Heart J. 2012;164(2):215-221. DOI: 10.1016/j.ahj.2012.04.010

Doucet KM, Labinaz MX, Beauchesne LM, Burwash IG. Cardiogenic shock in takotsubo cardiomyopathy: A focus on management. Can J Cardiol. 2015;31(1):84-87. DOI: 10.1016/j.cjca.2014.09.025

Madias JE. Is hypothyroidism (on levothyroxine replacement) a precipitant of takotsubo syndrome? Int J Cardiol. 2015;187:29-30. DOI: 10.1016/j.ijcard.2015.03.355

Prasad A, Lerman A, Rihal CS. Apical ballooning syndrome (tako-tsubo or stress cardiomyopathy): A mimic of acute myocardial infarction. Am Heart J. 2008;155(3):408-417. DOI: 10.1016/j.ahj.2007.11.008

Virani SS, Khan AN, Mendoza CE, Ferreira AC, de Marchena E. Takotsubo cardiomyopathy, or broken-heart syndrome. Tex Heart Inst J. 2007;34(1):76-79.

Akashi YJ, Nef HM, Mollmann H, Ueyama T. Stress cardiomyopathy. Annu Rev Med. 2010;61:271-286. DOI: 10.1146/annurev.med.041908.191750

Redfors B, Vedad R, Angerås O, et al. Mortality in takotsubo syndrome is similar to mortality in myocardial infarction – A report from the SWEDEHEART. Int J Cardiol. 2015;185:282-289. DOI: 10.1016/j.ijcard.2015.03.162

Song BG, Hahn JY, Cho SJ, et al. Clinical characteristics, ballooning pattern, and long-term prognosis of transient left ventricular ballooning syndrome. Heart Lung. 2010;39(3):188-195. DOI: 10.1016/j.hrtlng.2009.07.006

Gopalakrishnan M, Hassan A, Villines D, Nasr S, Chandrasekaran M, Klein LW. Predictors of short- and long-term outcomes of takotsubo cardiomyopathy. Am J Cardiol. 2015;116(10):1586-1590. DOI: 10.1016/j.amjcard.2015.08.024

Singh K, Carson K, Hibbert B, Le May M. Natural history of cardiac arrest in patients with takotsubo cardiomyopathy. Am J Cardiol. 2015;115(10):1466-1472. DOI: 10.1016/j.amjcard.2015.02.023

Murakami T, Yoshikawa T, Maekawa Y, et al. Gender differences in patients with takotsubo cardiomyopathy: Multi-center registry from ack CCU network. PloS One. 2015;10(8):e0136655. DOI: 10.1371/journal.pone.0136655

Stiermaier T, Moeller C, Oehler K, et al. Long-term excess mortality in takotsubo cardiomyopathy: Predictors, causes and clinical consequences. Eur J Heart Fail. 2016. DOI: 10.1002/ejhf.494

Murugiah K, Wang Y, Desai NR, et al. Trends in short- and long-term outcomes for takotsubo cardiomyopathy among medicare fee-for-service beneficiaries, 2007 to 2012. JACC Heart Fail. 2016;4(3):197-205. DOI: 10.1016/j.jchf.2015.09.013

Kurisu S, Inoue I, Kawagoe T, et al. Presentation of tako-tsubo cardiomyopathy in men and women. Clin Cardiol. 2010;33(1):42-45. DOI: 10.1002/clc.20700

Panteghini M, Cuccia C, Bonetti G, Giubbini R, Pagani F, Bonini E. Single-point cardiac troponin T at coronary care unit discharge after myocardial infarction correlates with infarct size and ejection fraction. Clin Chem. 2002;48(9):1432-1436.

Licka M, Zimmermann R, Zehelein J, Dengler TJ, Katus HA, Kubler W. Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct size. Heart. 2002;87(6):520-524.

Daubert MA, Jeremias A. The utility of troponin measurement to detect myocardial infarction: Review of the current findings. Vasc Health Risk Manag. 2010;6:691-699.

Thakar S, Chandra P, Hollander G, Lichstein E. Electrocardiographic changes in takotsubo cardiomyopathy. Pacing Clin Electrophysiol. 2011;34(10):1278-1282. DOI: 10.1111/j.1540-8159.2011.03151.x

Mugnai G, Pasqualin G, Benfari G, et al. Acute electrocardiographic differences between takotsubo cardiomyopathy and anterior ST elevation myocardial infarction. J Electrocardiol. 2015;48(1):79-85. DOI: 10.1016/j.jelectrocard.2014.11.001

Ishihara M. Takotsubo cardiomyopathy and left ventricular outflow tract obstruction. Circulation Journal. 2015;79(4):758-760. DOI: 10.1253/circj.CJ-15-0089

Yoshioka T, Hashimoto A, Tsuchihashi K, et al. Clinical implications of midventricular obstruction and intravenous propranolol use in transient left ventricular apical ballooning (tako-tsubo cardiomyopathy). Am Heart J. 2008;155(3):526.e1-526.e7. DOI: 10.1016/j.ahj.2007.10.042

El Mahmoud R, Mansencal N, Pilliere R, et al. Prevalence and characteristics of left ventricular outflow tract obstruction in tako-tsubo syndrome. Am Heart J. 2008;156(3):543-548. DOI: 10.1016/j.ahj.2008.05.002

Angue M, Soubirou L, Vandroux D, et al. Beneficial effects of intravenous beta-blockers in tako-tsubo syndrome with dynamic left ventricular outflow tract obstruction and severe haemodynamic impairment. Int J Cardiol. 2014;177(2):e56-7. DOI: 10.1016/j.ijcard.2014.09.162

Isogai T, Matsui H, Tanaka H, Fushimi K, Yasunaga H. Early beta-blocker use and in-hospital mortality in patients with takotsubo cardiomyopathy. Heart. 2016. DOI: 10.1136/heartjnl-2015-308712

De Backer O, Debonnaire P, Gevaert S, Missault L, Gheeraert P, Muyldermans L. Prevalence, associated factors and management implications of left ventricular outflow tract obstruction in takotsubo cardiomyopathy: A two-year, two-center experience. BMC Cardiovasc Disord. 2014;14:147-2261-14-147. DOI: 10.1186/1471-2261-14-147

Santoro F, Ieva R, Musaico F, et al. Lack of efficacy of drug therapy in preventing takotsubo cardiomyopathy recurrence: A meta-analysis. Clin Cardiol. 2014;37(7):434-439. DOI: 10.1002/clc.22280

Elesber AA, Prasad A, Lennon RJ, Wright RS, Lerman A, Rihal CS. Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol. 2007;50(5):448-452. DOI: 10.1016/j.jacc.2007.03.050

Mendoza I, Novaro GM. Repeat recurrence of takotsubo cardiomyopathy related to inhaled beta-2-adrenoceptor agonists. World J Cardiol. 2012;4(6):211-213. DOI: 10.4330/wjc.v4.i6.211

Micallef T, Gruppetta M, Cassar A, Fava S. Takotsubo cardiomyopathy and severe hypothyroidism. J Cardiovasc Med (Hagerstown). 2011;12(11):824-827. DOI: 10.2459/JCM.0b013e3283403454

Eliades M, El-Maouche D, Choudhary C, Zinsmeister B, Burman KD. Takotsubo cardiomyopathy associated with thyrotoxicosis: A case report and review of the literature. Thyroid. 2014;24(2):383-389. DOI: 10.1089/thy.2012.0384

Aggarwal S, Papani R, Gupta V. Can thyroid break your heart? Role of thyroid in takotsubo cardiomyopathy: A single center retrospective study. Int J Cardiol. 2015;184:545-546. DOI: 10.1016/j.ijcard.2015.02.058

Martin CS, Ionescu LN, Barbu CG, et al. Takotsubo cardiomyopathy and transient thyrotoxicosis during combination therapy with interferon-alpha and ribavirin for chronic hepatitis C. BMC Endocr Disord. 2014;14:10-6823-14-10. DOI: 10.1186/1472-6823-14-10

Mannelli M, Gheri RG, De Feo ML, Malentacchi C, Serio M. Effects of thyroid replacement therapy on catecholamine plasma levels. J Endocrinol Invest. 1983;6(4):307-309. DOI: 10.1007/BF03347596

Schoolmeester WL, Jackman WM. Variant angina in the setting of hypothyroidism and beta blockade: A proposed mechanism. South Med J. 1979;72(7):776-778.

Tang YD, Kuzman JA, Said S, Anderson BE, Wang X, Gerdes AM. Low thyroid function leads to cardiac atrophy with chamber dilatation, impaired myocardial blood flow, loss of arterioles, and severe systolic dysfunction. Circulation. 2005;112(20):3122-3130. DOI: 10.1161/CIRCULATIONAHA.105.572883

Shewan LG, Coats AJS, Henein M. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal 2015;2:2 DOI: 10.17987/icfj.v2i1.4




DOI: http://dx.doi.org/10.17987/icfj.v11i0.439

Copyright (c) 2017 The Authors

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.